We are live on ! Find out more
ACIU icon

AC Immune
ACIU

40 hedge funds and large institutions have $100M invested in AC Immune in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $90.6M → $100M (+$9.74M)

0.21% more ownership

Funds ownership: 26.54% → 26.75% (+0.21%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 41 → 40 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

Holders
40
Holders Change
-1
Holders Change %
-2.44%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
11
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$12M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$451K
3
Millennium Management
Millennium Management
New York
+$286K
4
Artisan Partners
Artisan Partners
Wisconsin
+$229K
5
Citadel Advisors
Citadel Advisors
Florida
+$216K

Top Sellers

Rank Fund Capital Flow
1
DFO
Duquesne Family Office
New York
-$6.69M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.49M
3
PM
Prosight Management
Texas
-$747K
4
VF
Virtu Financial
New York
-$397K
5
Deutsche Bank
Deutsche Bank
Germany
-$341K
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
26
ProShare Advisors
Maryland
$109K -$16.3K -3,197 -14%
JP Morgan Chase
27
JP Morgan Chase
New York
$99K +$15.9K +3,113 +21%
MWNA
28
Marshall Wace North America
New York
$95K +$6.48K +1,272 +8%
AP
29
Appleton Partners
Massachusetts
$85K +$78.3K +15,360 New
LBC
30
Lawrence B. Cohen
$74K – – –
CSS
31
Cubist Systematic Strategies
Connecticut
$58K +$53K +10,397 New
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$34K +$31K +6,076 New
Bank of America
33
Bank of America
North Carolina
$26K +$24.1K +4,729 +52,544%
UBS Group
34
UBS Group
Switzerland
$21K -$1.75K -343 -8%
QT
35
Quantamental Technologies
New York
$11K +$10.5K +2,063 New
Citigroup
36
Citigroup
New York
$9K +$3.07K +603 +62%
Russell Investments Group
37
Russell Investments Group
United Kingdom
$8K +$7.26K +1,424 New
Barclays
38
Barclays
United Kingdom
$3K +$2.47K +484 New
Daiwa Securities Group
39
Daiwa Securities Group
Japan
$2K +$2.17K +425 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K -$902 -177 -41%
DFO
41
Duquesne Family Office
New York
– -$6.69M -1,324,935 Closed
VF
42
Virtu Financial
New York
– -$397K -78,569 Closed
PC
43
PA Capital
Virginia
– -$202K -40,055 Closed
OPPM
44
Opus Point Partners Management
New York
– -$201K -39,801 Closed
ECM
45
Element Capital Management
New York
– -$167K -33,102 Closed
SIM
46
Spark Investment Management
New York
– -$115K -22,900 Closed
CS
47
Credit Suisse
Switzerland
– -$80K -15,768 Closed
Jane Street
48
Jane Street
New York
– -$56K -11,116 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$41K -8,164 Closed
1
2

ACIU Hedge Fund Activity: Q2 2019 in Review

40 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2019, worth a combined $100M — up 11% from $90.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ACIU and 9 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 11 added.

The largest buyer was BVF Inc, adding an estimated $12M. The largest seller was Duquesne Family Office, exiting entirely with an estimated $6.69M sold.

  • 40 institutional investors held AC Immune (ACIU) as of Q2 2019, down from 41 in Q1 2019.
  • Funds reported $100M of AC Immune stock for Q2 2019, up 11% quarter-over-quarter.
  • 9 funds opened new AC Immune positions in Q2 2019 and 10 closed out, a net change of -1 holder.
  • The largest AC Immune buyer in Q2 2019 was BVF Inc, an estimated $12M added.
  • The largest AC Immune seller in Q2 2019 was Duquesne Family Office, an estimated $6.69M sold.

Based on aggregated 13F filings for Q2 2019.